Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Proietti

Showing results (21-30 of 280) with videos related to

Pageof 28
Sort By:
Heart Rhythm|July 24, 2025
Atrial fibrillation as a clinical model of geriatric syndrome: Epidemiologic evidence from contemporary studiesMarco Proietti, Giulio Francesco Romiti
Nature Medicine|January 7, 2026
Understanding the link between atrial fibrillation and cognitive declineMarco Proietti, Giulio Francesco Romiti
Heart (British Cardiac Society)|August 4, 2025
Cardiac cachexia and sarcopenia in patients with heart failure: need for an integrated approach to patients with chronic cardiovascular diseasesMarco Proietti, Giulio Francesco Romiti
European Journal of Internal Medicine|April 28, 2021
Impact of rate control in hospitalized patients with atrial fibrillation and sepsisGiulio Francesco Romiti, Marco Proietti
Internal and Emergency Medicine|May 4, 2019
Diuretic resistance in decompensated chronic heart failure: trying to get out of the "loop"Alberto Maria Marra, Marco Proietti
Thrombosis and Haemostasis|July 3, 2018
Use of NOACs in the Peri-Operative Management of Patients with Atrial Fibrillation: To Stop, Bridge or Continue?Marco Proietti, Deirdre A Lane
Thrombosis and Haemostasis|March 6, 2020
The Compelling Issue of Nonvitamin K Antagonist Oral Anticoagulant Adherence in Atrial Fibrillation Patients: A Systematic Need for New StrategiesMarco Proietti, Deirdre A Lane
Nature Reviews. Cardiology|January 12, 2026
Oral anticoagulant therapy after ablation for atrial fibrillationGiulio Francesco Romiti, Marco Proietti
Cardiology Clinics|May 7, 2016
Atrial Fibrillation and Stroke: Making Sense of Recent Observations on AnticoagulationMarco Proietti, Gregory Y H Lip
Journal of the American College of Cardiology|March 4, 2017
Reply: Apixaban Dosing in Chronic Kidney Disease: Differences Between U.S. and E.U. LabelingMarco Proietti, Gregory Y H Lip
Pageof 28

Showing results (21-30 of 280) with videos related to

Sort By:
Pageof 28
Heart Rhythm|July 24, 2025
Atrial fibrillation as a clinical model of geriatric syndrome: Epidemiologic evidence from contemporary studiesMarco Proietti, Giulio Francesco Romiti
Nature Medicine|January 7, 2026
Understanding the link between atrial fibrillation and cognitive declineMarco Proietti, Giulio Francesco Romiti
Heart (British Cardiac Society)|August 4, 2025
Cardiac cachexia and sarcopenia in patients with heart failure: need for an integrated approach to patients with chronic cardiovascular diseasesMarco Proietti, Giulio Francesco Romiti
European Journal of Internal Medicine|April 28, 2021
Impact of rate control in hospitalized patients with atrial fibrillation and sepsisGiulio Francesco Romiti, Marco Proietti
Internal and Emergency Medicine|May 4, 2019
Diuretic resistance in decompensated chronic heart failure: trying to get out of the "loop"Alberto Maria Marra, Marco Proietti
Thrombosis and Haemostasis|July 3, 2018
Use of NOACs in the Peri-Operative Management of Patients with Atrial Fibrillation: To Stop, Bridge or Continue?Marco Proietti, Deirdre A Lane
Thrombosis and Haemostasis|March 6, 2020
The Compelling Issue of Nonvitamin K Antagonist Oral Anticoagulant Adherence in Atrial Fibrillation Patients: A Systematic Need for New StrategiesMarco Proietti, Deirdre A Lane
Nature Reviews. Cardiology|January 12, 2026
Oral anticoagulant therapy after ablation for atrial fibrillationGiulio Francesco Romiti, Marco Proietti
Cardiology Clinics|May 7, 2016
Atrial Fibrillation and Stroke: Making Sense of Recent Observations on AnticoagulationMarco Proietti, Gregory Y H Lip
Journal of the American College of Cardiology|March 4, 2017
Reply: Apixaban Dosing in Chronic Kidney Disease: Differences Between U.S. and E.U. LabelingMarco Proietti, Gregory Y H Lip
Pageof 28